LeviSense Medical
LeviSense Medical is a Massachusetts-based MedTech company that develops the Pro-Daptive SensorCell Flotation System, a patented therapeutic support surface using hundreds of independently controlled air cells for pressure injury prevention and treatment in hospitals, nursing facilities, home care, and VA medical centers.
- Company typePrivate
- Founded2019
- HeadquartersBeverly, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What LeviSense Medical does
LeviSense Medical, Inc. is a Massachusetts-based medical technology company founded in 2019 that develops next-generation therapeutic support surfaces for the prevention and treatment of pressure injuries (pressure ulcers/bed sores). The company's core product is the Pro-Daptive SensorCell Flotation System, which uses proprietary SensorCell technology — hundreds of independently responsive 2.4-inch air cells that conform to a patient's body in real time, with programmable pressure from 0 to 70 mmHg in 2 mmHg increments and up to 5 inches of immersion. The system is controlled via a Pro-Daptive bedside monitor and offers features including Mobility Mode, Cavity Creation Mode, Heel Float, Dynamic Off-Loading, and independent microclimate airflow. The technology is protected by US Patents 12,642,725 and 8,572,783.
LeviSense's business model is asset-light: AKTC (Taiwan) manufactures the SensorCell components under a partnership, Blue Chip Medical Products assembles the finished devices at its US facility and serves as the exclusive US distributor, while AKTC handles worldwide ex-US distribution. Direct enterprise sales engagement also exists with the Veterans Health Administration, where LeviSense ran a multi-year Cooperative Research and Development Agreement across eight VA Medical Centers. The target customer segments are acute care hospitals, long-term and skilled nursing facilities, home healthcare settings, and VA facilities, addressing a US patient population of approximately 2.5 million pressure-injury cases annually at a system cost of roughly $26.8 billion.
The company is privately held and venture-backed (ICV Venture Engineering and Formation Venture Engineering are anchor investors), with cumulative disclosed funding of approximately $3.25 million. The ProDaptive SensorCell product achieved commercial launch in February 2026 via Blue Chip Medical Products at the NPIAP Annual Conference, and in June 2026 the company appointed veteran healthcare executive Shri Parikh (formerly EVP/President of Milliken Healthcare/OVIK Health) as CEO to lead commercialization and market expansion.
LeviSense Medical firmographics
Firmographics- Name
- LeviSense Medical
- Legal name
- LeviSense Medical, Inc.
- Website
- https://levisensemedical.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- LeviSense Medical is a Massachusetts-based MedTech company that develops the Pro-Daptive SensorCell Flotation System, a patented therapeutic support surface using hundreds of independently controlled air cells for pressure injury prevention and treatment in hospitals, nursing facilities, home care, and VA medical centers.
- Ownership category
- akta.pro rank
Where LeviSense Medical is headquartered
LocationHeadquarters
- HQ city
- Beverly
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
LeviSense Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Revenue model
- Therapeutic Support Surface Hardware Sales: Sale of Pro-Daptive SensorCell Flotation System as medical device hardware. The product is manufactured by AKTC (components and control system), assembled by Blue Chip Medical Products in the US, and sold through distribution channels to healthcare facilities and home care patients. Hardware sales model with potential for enterprise contracts with hospitals, VA facilities, and nursing homes.
- Technology Licensing: LeviSense licenses its SensorCell technology to partners. AKTC manufactures SensorCell components under license, and Blue Chip Medical Products assembles and distributes finished products. The company holds patents (US 12,642,725, US 8,572,783) protecting the technology.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
LeviSense Medical product offering
Product offeringCore offering
LeviSense Medical develops and licenses the Pro-Daptive SensorCell Flotation System, a powered advanced care therapeutic mattress that uses hundreds of independently responsive 2.4-inch air cells to prevent and treat pressure injuries (bedsores). The patented SensorCell platform combines programmable pressure control, cavity creation, dynamic off-loading, and independent microclimate management, and is sold through manufacturing partner AKTC and US distribution partner Blue Chip Medical Products.
Product overview
LeviSense Medical offers the Pro-Daptive™ SensorCell™ Flotation System as its core product, which is a next-generation therapeutic support surface for the prevention and treatment of pressure injuries. The system consists of the SensorCell™ technology platform (comprising hundreds of independent air cells), the Pro-Daptive™ Control Monitor for pressure management, and various product models (PDA-9100 series). The technology is designed for use across the continuum of care from ICU to home care settings, and is manufactured and distributed through partnerships with AKTC (for manufacturing) and Blue Chip Medical Products (for assembly and distribution in the US market).
Differentiator
Problem solved
Functional benefit
Brands
- Pro-Daptive: Pro-Daptive SensorCell Flotation System - a powered advanced care mattress providing therapeutic flotation for treatment and prevention of pressure injuries.
- SensorCell
Products and services
- Pro-Daptive SensorCell Flotation System A powered advanced care therapeutic mattress that combines SensorCell flotation technology with surface visualization and control to deliver programmable immersion, outstanding envelopment, and pressure redistribution for the prevention and treatment of pressure injuries (bedsores). Designed for ICU, acute care, bariatric (up to 800 lbs), long-term care, rehabilitation, and home care patients, and intended for hospital procurement, wound care specialists, nursing leadership, VA Medical Centers, skilled nursing facilities, and home healthcare providers.
Quantifiable outcome
- Reduces physical caregiver effort by 30% through Mobility Mode
- +4 more outcomes
Companies that use LeviSense Medical
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
LeviSense Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
LeviSense Medical partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- AKTC (Air Kinetic Technologies Corporation)coreTaiwan-based AKTC serves as manufacturing partner producing SensorCell components and control system for the Pro-Daptive therapeutic surface. AKTC leverages advanced manufacturing capabilities to ensure precision and reliability. As a global leader in therapeutic air systems founded in 1989, AKTC has sold millions of air pumps for air mattresses and DVT applications. AKTC also handles worldwide distribution outside the US through their established channels.
- Blue Chip Medical Products, Inc.coreBlue Chip Medical Products assembles the final Pro-Daptive therapeutic surfaces at their US manufacturing facility. With a long history of excellence in wound care and 28 years of experience, Blue Chip leverages vast distribution network and established relationships with hospitals, VA centers, nursing homes, and home healthcare providers. Blue Chip CEO Ron Resnick also serves on the LeviSense Advisory Board. Products available exclusively through Blue Chip's established distribution channels in the US.
- Veterans Health Administration (VHA)coreMulti-year Cooperative Research and Development Agreement with VHA Innovation Ecosystem's Innovators Network (VHAIE/iNET) Greenhouse Initiative. Eight VA Medical Centers collaborate on product development: Orlando VAMC (Lead), Sheridan VAMC, Cincinnati VAMC, VA Palo Alto, Pittsburgh VAMC, Western Colorado, Western North Carolina, and Northeast Ohio. Over 300 medical professionals provided design input, over 150 experienced the product. Phase One involved collecting feedback from frontline clinical users; Phase Two provided alpha systems for user experience testing. The VA is the largest healthcare provider in the world for people with spinal cord injury.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
LeviSense Medical competitors and assessment
Company assessmentBroad incumbents
- Hill-Rom (now Baxter): Hill-Rom's support surfaces business, now part of Baxter, is the dominant therapeutic surface franchise in US hospitals. Directly comparable category (therapeutic support surfaces for pressure injury prevention) with far larger installed base and GPO contracts.
- Stryker: Stryker's Medical division includes therapeutic beds and surfaces that compete for the same ICU/acute care purchasing decisions. Large incumbent with deep hospital salesforce and integrated bed/surface offerings.
- Invacare: Invacare's bed and support surface portfolio (now operating through Motion Concepts and its hospital bed line) competes for long-term care and home care therapeutic surface contracts.
Direct peers
- Arjo: Arjo (formed from Getinge's Patient & Post-Acute Care business) is a direct competitor in therapeutic support surfaces and pressure injury prevention, including low air loss and alternating pressure systems. Closest European comp.
- Joerns Healthcare: Joerns is a focused wound care and therapeutic surface manufacturer competing in skilled nursing, long-term care, and home care — directly overlapping LeviSense's primary customer segments.
- Blue Chip Medical Products: Blue Chip is both LeviSense's exclusive US distributor and a competing manufacturer of therapeutic support surfaces. Their overlap in product category is direct, even as the SensorCell line is co-branded.
- Span-America (Savaria): Span-America (acquired by Savaria) manufactures therapeutic mattresses and overlays for pressure injury prevention. Direct US competitor in long-term care and home care segments.
- Drive DeVilbiss Healthcare: Drive DeVilbiss manufactures a broad line of therapeutic support surfaces and hospital beds, competing in the same pressure injury prevention category at generally lower price points.
- Talley Group: UK-based manufacturer of pressure area care products including alternating pressure and low air loss mattresses — competes in similar acute and community care settings.
Regional players
- Linet Group: Linet is a European-based manufacturer of hospital beds with integrated therapeutic surfaces, primarily competing outside the US but expanding globally — a relevant international peer for AKTC-led expansion.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
LeviSense Medical social profiles
Digital presenceLeviSense Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
LeviSense Medical leadership team
Management profileNumber of profiles
Profiles12 records
LeviSense Medical funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LeviSense Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LeviSense Medical
What does LeviSense Medical do?
LeviSense Medical develops and licenses the Pro-Daptive SensorCell Flotation System, a powered advanced care therapeutic mattress that uses hundreds of independently responsive 2.4-inch air cells to prevent and treat pressure injuries (bedsores). The patented SensorCell platform combines programmable pressure control, cavity creation, dynamic off-loading, and independent microclimate management, and is sold through manufacturing partner AKTC and US distribution partner Blue Chip Medical Products.
Is LeviSense Medical a public or private company?
LeviSense Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was LeviSense Medical founded?
LeviSense Medical was founded in 2019. It employs 1 to 10 people.
Where is LeviSense Medical based?
LeviSense Medical is headquartered in Beverly, United States, in the North America region.
How does LeviSense Medical make money?
Two revenue lines are on record. Therapeutic Support Surface Hardware Sales are the primary driver. The others are technology Licensing.
Who are LeviSense Medical's main competitors?
Broad incumbents on record are Hill-Rom (now Baxter), Stryker and Invacare. Direct peers are Arjo, Joerns Healthcare, Blue Chip Medical Products, Span-America (Savaria), Drive DeVilbiss Healthcare and Talley Group. Linet Group is listed as a regional player.
Does LeviSense Medical have an API?
No public API is recorded for LeviSense Medical.